kidney disease

Ardelyx’s ambition to revolutionise kidney treatment

https://pharmaphorum.com/r-d/views-analysis-r-d/ardelyxs-ambition-to-revolutionise-kidney-treatment/

Mallinckrodt’s liver disease drug terlipressin edges FDA advisory panel

https://pharmaphorum.com/news/mallinckrodts-liver-disease-drug-terlipressin-edges-fda-advisory-panel/

3rd Chronic Kidney Disease Drug Development (CKD3) Summit

https://pharmaphorum.com/events/3rd-chronic-kidney-disease-drug-development-ckd3-summit-2/

3rd Chronic Kidney Disease Drug Development (CKD3) Summit

https://pharmaphorum.com/events/3rd-chronic-kidney-disease-drug-development-ckd3-summit/

Q&A: Novartis’ Eric Hughes on transplantation

https://pharmaphorum.com/r-d/views-analysis-r-d/novartis-eric-hughes-transplantation/

Smartphone screening project for kidney disease launched in the Netherlands

https://pharmaphorum.com/news/smartphone-screening-project-for-kidney-disease-launched-in-the-netherlands/

Calliditas pushing on with kidney disease drug after IPO success

https://pharmaphorum.com/r-d/views-analysis-r-d/calliditas-pushing-kidney-disease-drug-ipo-success/

Otsuka has high hopes for its ‘drug creation engine’ acquisition

https://pharmaphorum.com/news/otsuka-biotech-visterra-hierotope/

Close in 10 seconds

Pharmaphorum.com

Search